Impact of body mass index on adverse kidney events in diabetes mellitus patients: A systematic-review and meta-analysis

作者全名："Wan, Jing-Fang; Chen, Yan; Yao, Tian-Hua; Wu, Ya-Zhou; Dai, Huan-Zi"

作者地址："[Wan, Jing-Fang] Army Med Univ, Dept Neurol, Chongqing 400042, Peoples R China; [Chen, Yan] Chongqing Med Univ, Dept Nephrol, Chongqing 400052, Peoples R China; [Yao, Tian-Hua; Wu, Ya-Zhou] Army Med Univ, Hlth Stat, Chongqing 400038, Peoples R China; [Dai, Huan-Zi] Army Med Univ, Daping Hosp, Dept Nephrol, 10 Daping Changjiang Zhi Rd, Chongqing 400042, Peoples R China"

通信作者："Dai, HZ (通讯作者)，Army Med Univ, Daping Hosp, Dept Nephrol, 10 Daping Changjiang Zhi Rd, Chongqing 400042, Peoples R China."

来源：WORLD JOURNAL OF CLINICAL CASES

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:001158254900018

JCR分区：Q3

影响因子：1.1

年份：2024

卷号：12

期号：3

开始页：　

结束页：　

文献类型：Review

关键词：Obesity; Body mass index; Diabetes mellitus; Adverse kidney events; Systematic-review; Meta-analysis

摘要："<bold>Background: </bold>The incidence of chronic kidney disease among patients with diabetes mellitus (DM) remains a global concern. Long-term obesity is known to possibly influence the development of type 2 diabetes mellitus. However, no previous meta-analysis has assessed the effects of body mass index (BMI) on adverse kidney events in patients with DM. <bold>Aim: </bold>To determine the impact of BMI on adverse kidney events in patients with DM. <bold>Methods: </bold>A systematic literature search was performed on the PubMed, ISI Web of Science, Scopus, Ovid, Google Scholar, EMBASE, and BMJ databases. We included trials with the following characteristics: (1) Type of study: Prospective, retrospective, randomized, and non-randomized in design; (2) participants: Restricted to patients with DM aged >= 18 years; (3) intervention: No intervention; and (4) kidney adverse events: Onset of diabetic kidney disease [estimated glomerular filtration rate (eGFR) of < 60 mL/min/1.73 m(2) and/or microalbuminuria value of >= 30 mg/g Cr], serum creatinine increase of more than double the baseline or end-stage renal disease (eGFR < 15 mL/min/1.73 m(2) or dialysis), or death. <bold>Results: </bold>Overall, 11 studies involving 801 patients with DM were included. High BMI (>= 25 kg/m(2)) was significantly associated with higher blood pressure (BP) [systolic BP by 0.20, 95% confidence interval (CI): 0.15-0.25, P < 0.00001; diastolic BP by 0.21 mmHg, 95%CI: 0.04-0.37, P = 0.010], serum albumin, triglycerides [standard mean difference (SMD) = 0.35, 95%CI: 0.29-0.41, P < 0.00001], low-density lipoprotein (SMD = 0.12, 95%CI: 0.04-0.20, P = 0.030), and lower high-density lipoprotein (SMD = -0.36, 95%CI: -0.51 to -0.21, P < 0.00001) in patients with DM compared with those with low BMIs (< 25 kg/m(2)). Our analysis showed that high BMI was associated with a higher risk ratio of adverse kidney events than low BMI (RR: 1.22, 95%CI: 1.01-1.43, P = 0.036). <bold>Conclusion: </bold>The present analysis suggested that high BMI was a risk factor for adverse kidney events in patients with DM."

基金机构：Special Project for Improving Science and Technology Innovation Ability of Army Medical University [2022XLC09]

基金资助正文："Supported by Special Project for Improving Science and Technology Innovation Ability of Army Medical University, No. 2022XLC09."